JP Morgan Chase’s Jin Medical International ZJYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-31
Closed -$395 7766
2025
Q2
$395 Sell
31
-93
-75% -$1.42K ﹤0.01% 6716
2025
Q1
$1.84K Buy
+124
New +$2.06K ﹤0.01% 6555
2024
Q2
Sell
-1,057
Closed -$81.2K 7794
2024
Q1
$81.2K Buy
1,057
+900
+573% +$132K ﹤0.01% 5763
2023
Q4
$38.9K Sell
157
-116
-42% -$3.93K ﹤0.01% 6073
2023
Q3
$6.39K Buy
+273
New +$3.48K ﹤0.01% 6334

Other funds holding ZJYL

JP Morgan Chase's ZJYL Position: Q3 2025 in Review

JP Morgan Chase sold out of Jin Medical International (ZJYL) in Q3 2025, closing a stake of 31 shares — an estimated $395 sold.

JP Morgan Chase first reported a position in ZJYL in Q3 2023 and held it in 5 quarters. The position peaked at $81.2K in Q1 2024. 9 funds tracked by Wall St. Rank hold ZJYL as of Q3 2025.

  • JP Morgan Chase reported no remaining Jin Medical International position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 31 Jin Medical International shares in Q3 2025, an estimated $395.
  • JP Morgan Chase first reported a position in Jin Medical International in Q3 2023 and held it in 5 quarters.
  • JP Morgan Chase's Jin Medical International position peaked at $81.2K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Jin Medical International as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.